JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.
JP Morgan Downgrades Bioventus to Underweight
JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.
Related Posts
Evergy Q3 EPS $1.98 Beats $1.75 Estimate
Evergy (NYSE:EVRG) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.75 by 13.14 percent. This is a 14.45 percent increase over earnings of $1.73 per share from the same
Hongjiu Fruit Gets IPO Go-ahead but Cash Flow Concerns May Bite
Key Takeaways:
Hongjiu Fruit specializes in high-value fruit and was the biggest distributor of branded fresh fruit in China last year in revenue terms
The company’s rapid expansion of new retail channels has raised cash flow risks, with trade receivables surging above 5.9 billion yuan in the first five months of the year
mPhase Lists Initial EV Charging Locations In Florida Amid Intensifying EV Rivalry
mPhase Technologies, Inc (OTC: XDSL) completed selecting sites for the first five mPower EV charging locations in the State of Florida. The…